Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$3.38 - $4.22 $204,152 - $254,887
-60,400 Reduced 69.91%
26,000 $95,000
Q3 2022

Nov 14, 2022

SELL
$3.43 - $5.83 $337,855 - $574,255
-98,500 Reduced 53.27%
86,400 $311,000
Q2 2022

Aug 12, 2022

BUY
$4.41 - $5.69 $321,048 - $414,232
72,800 Added 64.94%
184,900 $978,000
Q1 2022

May 13, 2022

BUY
$4.81 - $6.99 $516,112 - $750,027
107,300 Added 2235.42%
112,100 $615,000
Q2 2020

Aug 14, 2020

SELL
$4.5 - $7.02 $167,850 - $261,845
-37,300 Reduced 88.6%
4,800 $32,000
Q1 2020

May 14, 2020

BUY
$2.87 - $5.49 $10,906 - $20,862
3,800 Added 9.92%
42,100 $196,000
Q4 2019

Feb 13, 2020

BUY
$3.84 - $4.86 $89,472 - $113,238
23,300 Added 155.33%
38,300 $162,000
Q3 2019

Nov 08, 2019

SELL
$4.86 - $6.05 $295,002 - $367,235
-60,700 Reduced 80.18%
15,000 $77,000
Q2 2019

Aug 14, 2019

BUY
$4.51 - $6.6 $30,668 - $44,880
6,800 Added 9.87%
75,700 $425,000
Q1 2019

May 15, 2019

BUY
$5.16 - $6.85 $355,524 - $471,965
68,900 New
68,900 $429,000
Q4 2018

Feb 13, 2019

SELL
$4.89 - $7.16 $4,890 - $7,160
-1,000 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$6.89 - $7.78 $6,890 - $7,780
1,000 New
1,000 $7,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $280M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.